Intensity Therapeutics所有资讯

Intensity Therapeutics | SC 13G：超过5%持股股东披露文件-LFP Management, LLC(5.4%)

06/08 05:32

Intensity Therapeutics | 4：持股变动声明-高管 Wesolowski John M

06/07 19:31

Intensity Therapeutics | 4：持股变动声明-董事 DUBIN THOMAS I H

05/16 10:24

Intensity Therapeutics | 3：首次持股声明-董事 DUBIN THOMAS I H

05/16 10:24

Intensity Therapeutics | 4：持股变动声明-高管 Wesolowski John M

03/08 07:11

Intensity Therapeutics | 4：持股变动声明-董事 Leahy Emer

03/08 07:06

Intensity Therapeutics | 4：持股变动声明-董事 GOLDBERG MARK A

03/08 07:06

Intensity Therapeutics | 4：持股变动声明-董事 Donovan Daniel

03/08 07:06

Intensity Therapeutics | 4：持股变动声明-高管 BENDER LEWIS H

03/08 07:06

Intensity Therapeutics | SC 13G：超过5%持股股东披露文件-Lewis H. Bender(16.1%)

02/14 11:25

Intensity Therapeutics | 4：持股变动声明-首席财务官 Talamo Joseph

2023/12/12 21:17

Intensity Therapeutics | 3：首次持股声明-首席财务官 Talamo Joseph

2023/12/12 21:15

Intensity Therapeutics | 4：持股变动声明-高管 Wesolowski John M

2023/07/22 04:11

Intensity Therapeutics | 3：首次持股声明-高管 Wesolowski John M

2023/06/30 07:57

Intensity Therapeutics | 3：首次持股声明-高管 BENDER LEWIS H

2023/06/30 07:56

Intensity Therapeutics | 3：首次持股声明-董事 GOLDBERG MARK A

2023/06/30 07:56

Intensity Therapeutics | 3：首次持股声明-董事 Leahy Emer

2023/06/30 07:56

Intensity Therapeutics | 3：首次持股声明-董事 Donovan Daniel

2023/06/30 07:55

Intensity Therapeutics | 3：首次持股声明-高管 Ahlers James M

2023/06/30 07:54

Intensity Therapeutics | D：发行公告

2015/06/13 03:53